Verici Dx plc (LON:VRCI – Get Free Report) shares were up 11.1% during trading on Tuesday . The stock traded as high as GBX 0.30 and last traded at GBX 0.25. Approximately 8,366,714 shares were traded during trading, an increase of 363% from the average session volume of 1,806,996 shares. The stock had previously closed at GBX 0.23.
Verici Dx Stock Up 11.1%
The stock has a 50-day moving average price of GBX 0.34 and a 200-day moving average price of GBX 0.47. The company has a debt-to-equity ratio of 3.03, a current ratio of 3.94 and a quick ratio of 8.49. The company has a market capitalization of £5.72 million, a P/E ratio of -0.28 and a beta of 1.26.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Further Reading
- Five stocks we like better than Verici Dx
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
